Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients.

Stephanie GuStephen DuszaElizabeth QuigleyHelen HaliasosAlina MarkovaMichael MarchettiAndrea P MoyChau DangShanu ModiDiana LakeSarah NoorMario E Lacouture

Published in: Breast cancer research and treatment (2023)

Pruritus is uncommon in patients on trastuzumab and pertuzumab, generally a chronic condition, with gabapentinoids or antihistamines representing effective therapies.

Keyphrases

epidermal growth factor receptor
metastatic breast cancer
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
tyrosine kinase
prognostic factors
atopic dermatitis
patient reported